SYNLOGIC, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SYNLOGIC, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00.
- SYNLOGIC, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $433.00K.
- SYNLOGIC, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $816.00K.
- SYNLOGIC, INC. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $20.00K.
- SYNLOGIC, INC. stock issued during period, value, new issues for fiscal 2021 was $81.04M.
- SYNLOGIC, INC. stock issued during period, value, new issues for fiscal 2019 was $57.00M, a 31.05% decline from fiscal 2018.
- SYNLOGIC, INC. stock issued during period, value, new issues for fiscal 2018 was $82.67M.
- SYNLOGIC, INC. stock issued during period, value, new issues for fiscal 2014 was $4.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2023-06-30 | $433.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $816.00K 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $81.04M 10-K · filed 2023-03-29 |
| 2021-09-30 | $48.44M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $32.58M 10-Q · filed 2022-08-11 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $57.00M 10-K · filed 2021-03-25 |
| 2019-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | |
| 2019-06-30 | $56.98M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $82.67M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2018-06-30 | $28.91M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $53.75M 10-Q · filed 2019-05-09 | |
| 2014-12-31 | $4.00K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |